ABMC Granted Product Patent For Nine-panel Drug Test.Business Editors KINDERHOOK, N.Y.--(BUSINESS WIRE)--April 29, 2002 American Bio Medica medica (māˑ·dē·k Corporation (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : ABMC ABMC American Battle Monuments Commission ABMC Alexian Brothers Medical Center (Illinois) ABMC Aviation Battle Management Concept ABMC Arrowbear Music Camp (California) ) today announced that the U.S. Patent and Trademark office has issued a utility patent related to the Company's 9 panel Rapid Drug Screen(R) onsite test for drugs of abuse. The Company was previously issued a design patent related to its 9 panel test in August 2000. The U.S. Patent, No. US 6,372,515, covers the Rapid Drug Screen test card and relates to the test card having strips on both sides. The patent is not limited to a specific number of strips on a side. This additional patent further strengthens the Company's intellectual property rights related to its Rapid Drug Screen product line. The 9 panel Rapid Drug Screen is designed for use in clinical settings such as hospitals and physicians' offices. "While we have enjoyed tremendous sales momentum in recent months, our focus on researching, developing, and patenting on-site diagnostic technologies has never been stronger," said Gerald Moore
abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approvals we have received, this patent adds to our proprietary strength in the on-site drugs of abuse testing market." About American Bio Medica Corporation American Bio Medica Corporation develops, manufactures and markets inexpensive, accurate, on-site drugs-of-abuse diagnostic kits, sprays and support services support services Psychology Non-health care-related ancillary services–eg, transportation, financial aid, support groups, homemaker services, respite services, and other services worldwide. The company's global distributors target the workplace, physicians, corrections, clinical, and educational markets. ABMC's Rapid Drug Screen and OralStat6(TM) test for the presence of absence of drugs of abuse in urine and saliva, respectively, while its Drug Detector(TM) identifies minute traces of illegal drugs on surfaces. ABMC was recently listed among the top ten biotechnology companies on the Deloitte & Touche 2001 Technology Fast 500, a ranking of the fastest growing companies in North America. Forward-looking statements in this release are made pursuant to the "safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. " provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Investors are cautioned that such forward-looking statements involve risk and uncertainties, including without limitation, continued acceptance of the Company's products, increased levels of competition for the Company, new products and technological changes, intellectual property rights and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion